Extraskeletal myxoid chondrosarcoma (EMC) is aggressive in children. The condition in children differs to that in adults and to skeletal myxoid chondrosarcoma. We report on a 9-year-old girl with EMC in her left thigh. She underwent above-knee amputation. Five months later, a small mass was noted at the right lower lobe of the lung. The patient underwent one course of ifosfamide, carboplatin, and etoposide chemotherapy, followed by resection of the mass and 8 more courses of chemotherapy. At the 2-year follow-up, she was in remission radiologically.
The condition is characterised by multinodular architecture, abundant myxoid matrix, and malignant chondroblast-like cells. 1 The occurrence of EMC peaks in the fifth and sixth decades of life; in children, EMC is rare and tends to be more aggressive. 1, 2 We report a 9-year-old girl with EMC in her left thigh treated with above-knee amputation and chemotherapy.
case report
In April 2011, a 9-year girl presented with a 3-month history of progressive swelling of the posterior left knee after falling from a bicycle. She was given a course of antibiotics for infection, but the swelling did not subside. The swelling (20x15x15 cm) was warm, erythematous, and fluctuant with mild tenderness, and involved the suprapatellar and posteromedial areas of the knee. The range of knee movement remained full.
Magnetic resonance imaging showed the mass encroaching into the supra-and infra-patellar fat pads and located within the intermuscular plane between the sartorius and vastus medialis, which were stretched but with no abnormal signal within (Fig. 1) . The femoral vessels were not encased by the mass. Biopsy showed sarcomatous infiltration with myxoid features.
Two weeks later, the tumour had protruded through the skin as an ulcerated lesion. The patient had several episodes of haemorrhage from the ulceration and required blood transfusions.
An above-knee amputation was performed (Fig. 2) , and the diagnosis of EMC was confirmed. No evidence of metastasis was detected, and postoperative radiotherapy was not given as the resection margin was tumour-free. Histologically, the tumour was composed of chondroid neoplastic cells infiltrating the surrounding muscle and fatty tissue (Fig. 3) .
Five months later, chest radiography and computed tomography of the chest showed a small sub-pleural mass at the posterobasal segment of the right lower lobe of the lung. She underwent one course of ifosfamide, carboplatin, and etoposide chemotherapy for paediatric soild tumours, which consisted of intravenous ifosfamide 1500 mg/m 2 / day (diluted in 1/2 normal saline, dextrose 5%) infused over 3 hours on days 1, 2, and 3, intravenous carboplatin 500 mg/m 2 /day (diluted in dextrose 5%) infused over one hour on day 1, and intravenous etoposide 100 mg/m 2 /day (diluted in normal saline) infused over 4 hours on days 1, 2, and 3. She then underwent right middle lobectomy and resection of the small sub-pleural mass. Histopathology of the pulmonary nodules was consistent with a metastasis. She underwent 8 more courses of chemotherapy, depending on the time of the recovery of her absolute neutrophil counts to >1 x10 9 /l (reference range, 1.8-7.8 x10 9 /l) and platelet count to >100 x10 9 /l (reference range, 150-450 x10 9 /l) prior to chemotherapy. At the 2-year follow-up, she was in remission radiologically.
discussion
The median diameter of EMC in adults is 7 cm, 1 and the median age of patients with EMC is about 50 years. 3 EMC is a slow-growing tumour in adults, but is more aggressive in children (Table) . [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Ulceration and intra-tumoural haemorrhage are common EMC complications. 12 EMC is distinguished from other sarcomas by its characteristic balanced chromosomal translocation t(9;22)(q22;q12), which results in the fusion gene EWS-CHN. 12 This abnormality is noted in 50 to 75% of patients. 1 Compared with skeletal myxoid chondrosarcoma, EMC differs at the ultrastructural and molecular levels, despite having similar light microscopy features. 13 Furthermore, EMC demonstrates ultrastructural evidence of neuroendocrine differentiation and therefore is unlikely to be related to conventional skeletal myxoid chondrosarcoma. 13 The resultant fusion gene products are responsible for alterations in cellular growth and cellular differentiation. 
